首页> 外国专利> Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases

Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases

机译:从胚胎细胞中分化出来的多巴胺能神经元用于治疗神经退行性疾病

摘要

Disclosed herein are methods for generating dopaminergic neurons in vitro by inhibiting a pathway component of a TGF-β signaling pathway and overexpressing one or more cell fate-inducing polypeptides in pluripotent cells, causing differentiation of the pluripotent cells into dopaminergic neurons. Also disclosed are methods for treating a neurodegenerative disease in a patient by generating dopaminergic neurons in vitro and transplanting them into the brain of the patient, such that the dopaminergic neurons are sufficient to reduce or eliminate the symptoms of the neurodegerative disease.
机译:本文公开了通过抑制TGF-β信号传导途径的途径组分并在多能细胞中过表达一种或多种诱导细胞命运的多肽,从而导致多能细胞分化为多巴胺能神经元而在体外产生多巴胺能神经元的方法。还公开了通过在体外产生多巴胺能神经元并将其移植到患者大脑中来治疗患者神经退行性疾病的方法,使得多巴胺能神经元足以减轻或消除神经退行性疾病的症状。

著录项

  • 公开/公告号AU2003296316A8

    专利类型

  • 公开/公告日2004-06-30

    原文格式PDF

  • 申请/专利权人 THE MCLEAN HOSPITAL CORPORATION;

    申请/专利号AU20030296316

  • 发明设计人 LARS BJORKLUND;OLE ISACSON;

    申请日2003-12-09

  • 分类号C12Q1/68;A01N43/04;A61K31/70;C07H21/04;C12N5/00;C12N5/02;

  • 国家 AU

  • 入库时间 2022-08-21 23:01:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号